| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 11/16/2005 | EP1594958A2 Activation and expansion of cells |
| 11/16/2005 | EP1594897A2 Use of il-6 antagonists in combination with steroids to enhance apoptosis |
| 11/16/2005 | EP1594896A1 Modified soluble t cell receptor |
| 11/16/2005 | EP1594895A1 Growth factor complexes and modulation of cell migration and growth |
| 11/16/2005 | EP1594886A1 Antitumoral d-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates |
| 11/16/2005 | EP1594885A1 Medicament for inhibiting tumour growth |
| 11/16/2005 | EP1594866A1 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives |
| 11/16/2005 | EP1594858A2 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 11/16/2005 | EP1594857A2 N-monoacylated o-phenylenediamines as anti-cancer agents |
| 11/16/2005 | EP1594849A2 Compounds, compositions, and methods |
| 11/16/2005 | EP1594841A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines |
| 11/16/2005 | EP1594542A2 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 11/16/2005 | EP1594501A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 11/16/2005 | EP1594497A1 Sulfhydantoins as phosphate isosteres for use as phosphatase inhibitors in the treatment of cancer and autoimmune disorders |
| 11/16/2005 | EP1594491A1 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 11/16/2005 | EP1594489A2 A method of treating breast cancer with androgen receptor antagonists |
| 11/16/2005 | EP1594488A2 Stabilized pharmaceutical compositions of safingol and methods of using the same |
| 11/16/2005 | EP1594486A2 Uses of acylated aminopropanediols and sulphur and nitrogen analogues of same |
| 11/16/2005 | EP1594439A2 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS |
| 11/16/2005 | EP1594433A2 Cancer therapy sensitizer |
| 11/16/2005 | EP1498129B1 Use of adenoviruses mutated in the va genes for cancer treatment |
| 11/16/2005 | EP1496895B1 Use of cyclopamine in the treatment of psoriasis and other skin disorders |
| 11/16/2005 | EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 11/16/2005 | EP1341928B1 Methods and kits for detecting protein kinases |
| 11/16/2005 | EP1324809B1 Process for selectively extracting bioactive components |
| 11/16/2005 | EP1317442B1 Quinolinone derivatives as tyrosine kinase inhibitors |
| 11/16/2005 | EP1309338B1 Pharmaceutical composition comprising trkaig2 for use in the prevention and/or treatment of cancer |
| 11/16/2005 | EP1299085B1 Improved liposomal camptothecins and uses thereof |
| 11/16/2005 | EP1299084B1 Liposomal antineoplastic drugs and uses thereof |
| 11/16/2005 | EP1294927B1 Screening-method for modulators of methyltransferase-dependent chromosome stability |
| 11/16/2005 | EP1292319B1 Extracts from spermatophyte plants with antitumor activity |
| 11/16/2005 | EP1289517B1 Pharmaceutical compositions comprising cannabidiol derivatives |
| 11/16/2005 | EP1222191B1 Benzodiazepin derivatives, the production and use thereof |
| 11/16/2005 | EP1222182B1 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 11/16/2005 | EP1221966B1 Use of a parathyroid hormone for reducing the risk of cancer |
| 11/16/2005 | EP1218374B1 Pharmaceutically active sulfonamide derivatives |
| 11/16/2005 | EP1114052B1 4-aminopyrrolopyrimidines as kinase inhibitors |
| 11/16/2005 | EP1100515B1 EX VIVO TREATMENT OF ALLOGENEIC AND XENOGENEIC T-CELLS WITH gp39 ANTAGONISTS |
| 11/16/2005 | EP0981517B1 Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides |
| 11/16/2005 | EP0977738B1 Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer |
| 11/16/2005 | EP0876395B1 Inhibitors of interleukin-1beta converting enzyme |
| 11/16/2005 | CN1697878A Novel peptides having cAMP producing activity |
| 11/16/2005 | CN1697830A 嘧啶衍生物 Pyrimidine derivatives |
| 11/16/2005 | CN1697828A New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 11/16/2005 | CN1697663A Antitumor agent and process for producing the same |
| 11/16/2005 | CN1697655A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 11/16/2005 | CN1696293A Gene recombined chemotaxis antigen vaccine |
| 11/16/2005 | CN1227361C Method of expressing thymus peptide alpha by yeast and use thereof |
| 11/16/2005 | CN1227360C Tumor-associated antigen derivatives from MAGE family, and nucleic acid sequence encoding them |
| 11/16/2005 | CN1227267C Spiruline polyose, its extraction process and it medical application in increasing white cells and treating cancer |
| 11/16/2005 | CN1227265C Antibodies to CCR5 |
| 11/16/2005 | CN1227264C Immunogenic peptides derived from MAGE and use thereof |
| 11/16/2005 | CN1227249C Pyrimidine compounds |
| 11/16/2005 | CN1227248C Imidazolidine derivatives, their preparation, and their use as antinflamatory agent |
| 11/16/2005 | CN1227247C Method for producing therapeutic agents for ulcers |
| 11/16/2005 | CN1227245C Food product and producing method |
| 11/16/2005 | CN1227035C Conjugates and method for production thereof, and their use for transporting molecules via biological membranes |
| 11/16/2005 | CN1227033C Method of treating cancer with anti-neurotrophin agents |
| 11/16/2005 | CN1227030C Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 11/16/2005 | CN1227027C Novel compositions |
| 11/16/2005 | CN1227010C Usage of substituted tetrahydroisoquinoline derivation |
| 11/16/2005 | CN1227007C Cannabinoid drugs |
| 11/16/2005 | CN1226999C Solubilized pharmaceutical composition for parenteral administration |
| 11/16/2005 | CN1226982C Oil-in-water emulsion comprising micronised biologically active agent and appropriate emulsified system |
| 11/15/2005 | US6965027 Crystalline 3-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate |
| 11/15/2005 | US6965024 Reactive with ganglioside GD3; cancer treatment |
| 11/15/2005 | US6965018 Antibodies directed to B7-related polypeptide, BSL-2 |
| 11/15/2005 | US6965017 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 11/15/2005 | US6965010 Polypeptideeptide for use in the treatment of cancer, neovascularization defects, retinopathies, arthritis and psoraisis |
| 11/15/2005 | US6964983 Compounds that modulate PPAR activity and methods for their preparation |
| 11/15/2005 | US6964978 Dissolving with crystal growth inihibitos; drying |
| 11/15/2005 | US6964977 E.g., 5-(((Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-amino)-1,3-dihydro-2H -benzimidazol-2-one; inhibition or antagonism of protein kinases; treating pain or cancer |
| 11/15/2005 | US6964975 Isoxazole and thiazole compounds and use thereof as medicine |
| 11/15/2005 | US6964974 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 11/15/2005 | US6964973 Nonsteroidal agonists and antagonists |
| 11/15/2005 | US6964971 Oral administering; sustained release |
| 11/15/2005 | US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use |
| 11/15/2005 | US6964965 Corticotropin releasing factor antagonists |
| 11/15/2005 | US6964961 Antiproliferative agents for mammals |
| 11/15/2005 | US6964960 Indoloquinazolinones |
| 11/15/2005 | US6964959 Use of a methylol-containing compound to treat tumors |
| 11/15/2005 | US6964957 For use in therapy of neurodegenerative diseases and certain cancers |
| 11/15/2005 | US6964956 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization |
| 11/15/2005 | US6964955 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol |
| 11/15/2005 | US6964946 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| 11/15/2005 | US6964785 Herbal composition for improving anticancer activity, immune response and hematopoiesis of the body, and protecting the body from oxidative damage, and the method of preparing the same |
| 11/15/2005 | US6964784 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
| 11/15/2005 | US6964769 Molecular antigen array |
| 11/15/2005 | CA2437962C Method of extracting virus from cell culture |
| 11/15/2005 | CA2164847C O6-substituted guanine derivatives, a process for their preparation and their use in treating tumour cells |
| 11/15/2005 | CA2130031C Urea-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them |
| 11/15/2005 | CA2111512C 3,5-substituted aminobenzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 11/15/2005 | CA2070120C Thioxanthenone antitumor agents |
| 11/13/2005 | CA2507567A1 Use of compositions comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditions |
| 11/10/2005 | WO2005106039A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 11/10/2005 | WO2005106019A1 Granulin-epithelin precursor (gep) overexpression as a target for diagnosis, prognosis and treatment of hepatocellular carcinoma (hcc) |
| 11/10/2005 | WO2005105826A1 Tyropeptin a analogue |
| 11/10/2005 | WO2005105823A1 Steroid derivatives |
| 11/10/2005 | WO2005105807A1 Process for producing pentacyclic taxane |
| 11/10/2005 | WO2005105805A1 Annelated carbamoylase-heterocycles, focused library, pharmaceutical compositions and methods for the production thereof |